Published in Blood Weekly, September 28th, 2000
"Organ transplantation has become an accepted means of treating end-stage organ disease in recent years with acceptable patient and graft survival," wrote G.B. Zibari and colleagues, Louisiana State University. "Transplant recipients have an increased risk of infectious complications due to multiple factors including decreased host resistance from chronic end-stage organ failure as well as from the immunosuppression required to prevent graft rejection. Therefore, the use of contaminated allografts could result in life-threatening infections in organ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.